Biomarkers

Fapon Group inked a memorandum of cooperation with C.I.C.

On November 2, 2023, Fapon Group (Fapon), at the invitation of Dubai Business Forum 2023, inked a memorandum of cooperation (MoC) with China Innovation Center (C.I.C.) at Dubai Chambers during the event. This collaboration aims to cultivate strategic partnerships in in-vitro-diagnostics (IVD), pharmaceuticals, therapeutics, biomarker screening and healthcare-related investments, which will boost the development of Dubai’s healthcare industry

The MoC will pave the way for both sides to leverage their respective expertise by jointly organizing investment promotion fairs, webinars, seminars and technical conferences. The objective is to support local medical and diagnostic companies and offer more superior and accessible medical services and solutions for the local healthcare industry.

C.I.C. at Dubai Chambers is committed to ushering in a new era of technological and economic cooperation between China and Dubai. It serves as a significant platform for Chinese tech-innovation companies to showcase their capabilities and connect with potential clients among the Gulf Cooperation Council regions. Capitalizing on its strengths in technologies, solutions and ecosystem resources in the fields of IVD, innovative biopharma, and AI-enabled diagnostics and therapeutics, Fapon, as a trustworthy partner, will utilize the C.I.C. at Dubai Chambers’ platform to deliver innovative technologies and services that will enhance the local healthcare industry.

Jielun ZHU, the Chief Financial Officer and Chief Investment Officer of Fapon, stated that Dubai serves as a hub in Belt and Road initiative, and acts as a gateway to markets in West Asia, North Africa and South Asia. The partnership marks a significant milestone in Fapon’s globalization strategy which will strengthen its presence in Dubai or the Middle East region. Fapon aims to introduce its innovative technologies, products and services in diagnostics and therapeutics to help local partners increase R&D and production efficiency, deepen collaboration within the local healthcare sector, optimize the local healthcare structure and eventually improve the local healthcare services.

Hamdan Zakaria Doleh, Chairman of C.I.C., stated that against the backdrop of the Dubai Global initiative launched by HH Sheikh Hamdan, the Crown Prince of Dubai, in 2022, C.I.C. at Bubai Chambers is dedicated to elevating the technological and economic collaboration between China and Dubai. The alliance with Fapon to invoke the IVD industry in Dubai is a significant step towards enhancing Dubai’s healthcare sector. He also voiced his confidence in Fapon, a globally recognized supplier, stating that the integration of Fapon’s technologies in Dubai will undoubtedly prosper and bring benefits to local partners.

Fapon entered the overseas market in 2007. With its diverse portfolios and rapid development, the Company has established presence in 68 countries and regions. The collaboration will enable Fapon to tap into the Middle East market, and further expedite its global expansion. Middle East, as an emerging market that has the potential to further connect to bigger markets, plays a critical role in Fapon’s globalization strategy.

In the future, in alignment with the Belt and Road initiative, Fapon will continue its dedication towards global market expansion and advance the global healthcare by leveraging its expertise.

Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!

Related posts

William P. Donnelly appointed to Quanterix’s Board of Directors

Business Wire

Ozette Technologies Announces New Collaboration with Umoja Biopharma

Business Wire

Genialis announced the addition of several new team members

Business Wire